Interactions between the -514C→T polymorphism of the hepatic lipase gene and lifestyle factors in relation to HDL concentrations among US diabetic men

American Journal of Clinical Nutrition

Volumn 81, Issue 6, 2005, Pages 1429-1435

  Zhang, Cuilin ^a   Lopez Ridaura, Ruy ^a,b   Rimm, Eric B ^a,b   Rifai, Nader ^c   Hunter, David J ^a,b   Hu, Frank B ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

514C T polymorphism; Body mass index; Dietary fat; HDL; Health Professionals Follow Up Study; Hepatic lipase gene; Interactions; Type 2 diabetes

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER TRIACYLGLYCEROL LIPASE; HEPATIC LIPASE, HUMAN; TRIACYLGLYCEROL LIPASE;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CONTROLLED STUDY; DNA POLYMORPHISM; FAT INTAKE; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HEMOGLOBIN DETERMINATION; HUMAN; LIFESTYLE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; SMOKING; BLOOD; COHORT ANALYSIS; ENZYMOLOGY; EXERCISE; FOLLOW UP; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HYPERLIPIDEMIA; LIVER; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY;

ADULT; AGED; BODY MASS INDEX; CHOLESTEROL, HDL; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIETARY FATS; EXERCISE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERLIPIDEMIAS; LIFE STYLE; LIPASE; LIVER; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES;

EID: 21944446578     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/81.6.1429     Document Type: Article

References (50)

1. Garg A, Grundy SM. Management of dyslipidemia in NIDDM. Diabetes Care 1990;13:153-69.
2. Cohen JC, Wang Z, Grundy SM, Stoesz MR, Guerra R. Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J Clin Invest 1994;94:2377-84.
3. Jansen H, Verhoeven AJ, Weeks L, et al. Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol 1997;17:2837-42.
4. Guerra R, Wang J, Grundy SM, Cohen JC. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci U S A 1997;94:4532-7.
5. Freeman DJ, Griffin BA, Holmes AP, et al. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb 1994;14:336-44.
6. Deeb SS, Zambon A, Carr MC, Ayyobi AF, Brunzell JD. Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet. J Lipid Res 2003;44:1279-86.
7. Jansen H, Verhoeven AJ, Sijbrands EJ. Hepatic lipase: a pro- or anti-atherogenic protein? J Lipid Res 2002;43:1352-62.
8. Applebaum-Bowden D. Lipases and lecithin: cholesterol acyltransferase in the control of lipoprotein metabolism. Curr Opin Lipidol 1995; 6:130-5.
9. Thuren T. Hepatic lipase and HDL metabolism. Curr Opin Lipidol 2000; 11:277-83.
10. Fan J, Watanabe T. Hepatic lipase. J Atheroscler Thromb 1998;5:41-5.
11. Deckelbaum RJ, Ramakrishnan R, Eisenberg S, Olivecrona T, Bengtsson-Olivecrona G. Triacylglycerol and phospholipid hydrolysis in human plasma lipoproteins: role of lipoprotein and hepatic lipase. Biochemistry 1992;31:8544-51.
12. Shirai K, Barnhart RL, Jackson RL. Hydrolysis of human plasma high density lipoprotein 2- phospholipids and triglycerides by hepatic lipase. Biochem Biophys Res Commun 1981;100:591-9.
13. Cohen JC, Vega GL, Grundy SM. Hepatic lipase: new insights from genetic and metabolic studies. Curr Opin Lipidol 1999;10:259-67.
14. Cooper AD. Hepatic uptake of chylomicron remnants. J Lipid Res 1997; 38:2173-92.
15. Carr MC, Brunzell JD, Deeb SS. Ethnic differences in hepatic lipase and HDL in Japanese, black, and white Americans: role of central obesity and LIPC polymorphisms. J Lipid Res 2004;45:466-73.
16. Vega GL, Gao J, Bersot TP, et al. The -514 polymorphism in the hepatic lipase gene (LIPC) does not influence androgen-mediated stimulation of hepatic lipase activity. J Lipid Res 1998;39:1520-4.
17. Tahvanainen E, Pajukanta P, Porkka K, et al. Haplotypes of the ApoA-I/C-III/A-IV gene cluster and familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 1998;18:1810-7.
18. Botma GJ, Verhoeven AJ, Jansen H. Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by upstream stimulatory factor. Atherosclerosis 2001;154:625-32.
19. Deeb SS, Peng R. The C-514T polymorphism in the human hepatic lipase gene promoter diminishes its activity. J Lipid Res 2000;41:155-8.
20. Zambon A, Deeb SS, Hokanson JE, Brown BG, Brunzell JD. Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Arterioscler Thromb Vasc Biol 1998;18:1723-9.
21. Ordovas JM, Corella D, Demissie S, et al. Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: evidence of a strong dose effect in this gene-nutrient interaction in the Framingham Study. Circulation 2002;106:2315-21.
22. Tai ES, Corella D, Deurenberg-Yap M, et al. Dietary fat interacts with the -514C→T polymorphism in the hepatic lipase gene promoter on plasma lipid profiles in a multiethnic Asian population: the 1998 Singapore National Health Survey. J Nutr 2003;133:3399-408.
23. Nie L, Wang J, Clark LT, et al. Body mass index and hepatic lipase gene (LIPC) polymorphism jointly influence postheparin plasma hepatic lipase activity. J Lipid Res 1998;39:1127-30.
24. Talmud PJ, Hawe E, Robertson K, Miller GJ, Miller NE, Humphries SE. Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middleaged men. Ann Intern Med 2002;66:111-24.
25. St-Pierre J, Miller-Felix I, Paradis ME, et al. Visceral obesity attenuates the effect of the hepatic lipase -514C→T polymorphism on plasma HDL-cholesterol levels in French Canadian men. Mol Genet Metab 2003;78:31-6.
26. Ko YL, Hsu LA, Hsu KH, Ko YH, Lee YS. The interactive effects of hepatic lipase gene promoter polymorphisms with sex and obesity on high-density- lipoprotein cholesterol levels in Taiwanese Chinese. Atherosclerosis 2004;172:135-42.
27. Rimm EB, Giovannucci EL, Willett WC, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991; 338:464-8.
28. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 1979;28: 1039-57.
29. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
30. Hu FB, Leitzmann MF, Stampfer MJ, Colditz GA, Willett WC, Rimm EB. Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med 2001;161:1542-8.
31. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992;135:1114-26.
32. Giovannucci E, Colditz G, Stampfer MJ, et al. The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol 1991;133:810-7.
33. Willett W, Stampfer MJ, Bain C, et al. Cigarette smoking, relative weight, and menopause. Am J Epidemiol 1983;117:651-8.
34. Murtomaki S, Tahvanainen E, Antikainen M, et al. Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants. Eur Atheroscler Res Study Arterioscler Thromb Vasc Biol 1997;17:1879-84.
35. Couture P, Otvos JD, Cupples LA, et al. Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 2000;20:815-22.
36. Inazu A, Nishimura Y, Terada Y, Mabuchi H. Effects of hepatic lipase gene promoter nucleotide variations on serum HDL cholesterol concentration in the general Japanese population. J Hum Genet 2001;46:172-7.
37. Jansen H, Chu G, Ehnholm C, Dallongeville J, Nicaud V, Talmud PJ. The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII:B: European Atherosclerosis Research Study (EARS) II. Arterioscler Thromb Vasc Biol 1999;19:303-8.
38. Connelly PW. The role of hepatic lipase in lipoprotein metabolism. Clin Chim Acta 1999;286:243-55.
39. Sibley SD, Palmer JP, Hirsch IB, Brunzell JD. Visceral obesity, hepatic lipase activity, and dyslipidemia in type 1 diabetes. J Clin Endocrinol Metab 2003;88:3379-84.
40. Carr MC, Hokanson JE, Zambon A, et al. The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity. J Clin Endocrinol Metab 2001;86: 2831-7.
41. Cominacini L, Garbin U, Davoli A, et al. High-density lipoprotein cholesterol concentrations and postheparin hepatic and lipoprotein lipases in obesity: relationships with plasma insulin levels. Ann Nutr Metab 1993; 37:175-84.
42. Katzel LI, Coon PJ, Busby MJ, Gottlieb SO, Krauss RM, Goldberg AP. Reduced HDL2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia. Arterioscler Thromb 1992;12:814-23.
43. Ronnemaa T, Marniemi J, Savolainen MJ, et al. Serum lipids, lipoproteins, and lipid metabolizing enzymes in identical twins discordant for obesity. J Clin Endocrinol Metab 1998;83:2792-9.
44. Patsch JR, Prasad S, Gotto AM Jr, Patsch W. High density Lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 1987;80:3417.
45. Tall AR. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J Clin Invest 1990;86:379-84.
46. De Oliveira e Silva ER, Kong M, Han Z, et al. Metabolic and genetic determinants of HDL metabolism and hepatic lipase activity in normolipidemic females. J Lipid Res 1999;40:1211-21.
47. Machicao F, Staiger H, Fritsche A, et al. Association of the -514C-→T polymorphism in the hepatic lipase gene (LIPC) promoter with elevated fasting insulin concentrations, but not insulin resistance, in non-diabetic Germans. Horm Metab Res 2004;36:303-6.
48. Todorova B, Kubaszek A, Pihlajamaki J, et al. The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study. J Clin Endocrinol Metab 2004;89:2019-23.
49. Chen W, Srinivasan SR, Boerwinkle E, Berenson GS. Hepatic lipase promoter C-514T polymorphism influences serial changes in HDL cholesterol levels since childhood: the Bogalusa Heart Study. Atherosclerosis 2003;169:175-82.
50. Shohet RV, Vega GL, Anwar A, Cigarroa JE, Grundy SM, Cohen JC. Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations. Arterioscler Thromb Vasc Biol 1999; 19:1975-8.